PainReform Ltd (PRFX): קונצנזוס שווי הוגן
The price action history of PainReform Ltd. (PRFX) on the GURU.Markets platform, where the indicator stands at 240.22, demonstrates the development trajectory of this long-term pain management systems developer. The business is protected by exclusive patents for the Plex03 platform, despite stringent FDA oversight. Stable management is currently focusing on completing tests, which, combined with the success of PRF-110 and the demand for opioid alternatives, is driving commercial growth.
%20-%20%D7%AA%D7%97%D7%96%D7%99%D7%AA%20%D7%A7%D7%95%D7%A0%D7%A6%D7%A0%D7%96%D7%95%D7%A1%20%D7%90%D7%A0%D7%9C%D7%99%D7%A1%D7%98%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvj9owew.wip-79mfnr4&start=20220704&end=20261022&filename=GURU_Markets_-_PRFX_-_PainReform-Ltd._-_Analyst-Consensus-Forecast "PRFX - גרף רמות תחזית painreform.com בטווח 04.07.2022 - 22.10.2026 | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת PainReform Limited (PRFX)
The consensus forecast dynamics for the market value of PainReform Ltd. (PRFX) reflect market expectations regarding the commercial success of PainReform Ltd. (PRFX) biopolymer developments in the field of local anesthesia. This indicator represents a weighted average of target prices from leading analysts, capturing shifts in investor sentiment as new R&D data emerges, which allows for the prompt adjustment of capital management strategies based on professional valuations.